| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/19/2022 | 204.51% | Maxim Group | $8 → $3 | Maintains | Buy |
| 11/09/2022 | 712.02% | Maxim Group | → $8 | Initiates Coverage On | → Buy |
| 08/08/2022 | 712.02% | Benchmark | → $8 | Initiates Coverage On | → Speculative Buy |
What is the target price for Heart Test Laboratories (HSCS)?
The latest price target for Heart Test Laboratories (NASDAQ: HSCS) was reported by Maxim Group on December 19, 2022. The analyst firm set a price target for $3.00 expecting HSCS to rise to within 12 months (a possible 204.51% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Heart Test Laboratories (HSCS)?
The latest analyst rating for Heart Test Laboratories (NASDAQ: HSCS) was provided by Maxim Group, and Heart Test Laboratories maintained their buy rating.
When is the next analyst rating going to be posted or updated for Heart Test Laboratories (HSCS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Heart Test Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Heart Test Laboratories was filed on December 19, 2022 so you should expect the next rating to be made available sometime around December 19, 2023.
Is the Analyst Rating Heart Test Laboratories (HSCS) correct?
While ratings are subjective and will change, the latest Heart Test Laboratories (HSCS) rating was a maintained with a price target of $8.00 to $3.00. The current price Heart Test Laboratories (HSCS) is trading at is $0.99, which is out of the analyst's predicted range.